Further re REGULATORY APPROVAL

22 March 2006

                                  Lawrence plc
               ECO Animal Health - Update on Regulatory Approvals

On  13  February  2006 Lawrence plc announced that the Committee for  Veterinary
Medicinal Products (CVMP) of The European Agency for the Evaluation of Medicinal
Products  (EMEA)  would  meet  in mid March. At  that  meeting  the  CVMP  would
consider, amongst others, two Aivlosin applications for the treatment of enteric
(digestive)  diseases  in pigs submitted by ECO Animal Health,  a  wholly  owned
subsidiary of Lawrence plc.

In line with normal practice, ECO has not been formally advised of the decisions
reached  at  the  CVMP meeting but understands the committee's opinion  will  be
published  after the next EMEA meeting which will be held from 19  to  21  April
2006.


Contacts:

Peter Lawrence
Chairman, Lawrence plc
020 8336 2900

Anthony Spiro
Spiro Financial
020 8949 0428


Philip Davies
Charles Stanley Securities
020 7953 2457

Notes to Editors:
Lawrence  plc  is  a leader in the development, manufacture and distribution  of
principally  specialist  chemical and pharmaceutical  products  for  the  animal
health  and  farming  markets worldwide. Our products for these  growth  markets
incorporate  natural  ingredients to promote well being and  sustainability.  We
achieve  our financial goals through the careful and responsible application  of
science to generate value for our shareholders.